Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
28.05. | FDA fast-tracks Teva's coeliac disease treatment | ||
28.05. | Manufacturing issues scupper Savara's lead drug filing | ||
28.05. | Lilly takes on Vertex in non-opioid pain with SiteOne buy | ||
28.05. | CDC stops backing COVID jabs for pregnant women, children | ||
27.05. | UK cancer centre launches AI-powered detection drive | ||
27.05. | ASCO 25: Merus bispecific scores again in HNSCC | ||
27.05. | Sanofi admits giving free Olympics tickets to patients | ||
27.05. | Autolus closes on EU okay for leukaemia cell therapy | ||
27.05. | Roche takes new antibiotic into phase 3 for 'urgent threat' | ||
26.05. | ASCO 25: Can GLP-1 drugs reduce cancer risk? | ||
26.05. | ASCO 25: Jazz, PharmaMar reveal SCLC survival data | ||
23.05. | ASCO 25: Roche places Itovebi marker in breast cancer | ||
23.05. | RFK Jr spreading 'harmful myths' on Alzheimer's research | ||
23.05. | NICE relents and backs drug for IgAN from CSL Vifor | ||
23.05. | GSK claims first approval for Nucala in COPD | ||
23.05. | Digital player Hinge Health rises sharply after NYSE debut | ||
22.05. | AZ partners with Aptar on kidney disease-detecting AI | ||
22.05. | Sanofi makes Alzheimer's play with Vigil Neuroscience takeover | ||
22.05. | Pfizer's weekly haemophilia drug backed for NHS use | ||
22.05. | FDA tightens heart tox warnings on mRNA COVID vaccines | ||
22.05. | Mixed outcomes for pharma in big week for FDA adcomms | ||
21.05. | US imposes limits on COVID-19 boosters and new jabs | ||
21.05. | UK to start "world first" gonorrhoea vaccine programme | ||
21.05. | Beckley's psychedelic med inches forward in depression | ||
21.05. | UK trumpets £1bn investment plan from BioNTech |